Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancer

NCT05826509 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT05826509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05826509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancer
Lead sponsor
Institut Claudius Regaud
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 10, 2023
Completion date
February 28, 2031
Enrollment
240 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer